BTL, the manufacturer behind the game-changing EMSCULPT technology, is continuing to raise the bar in aesthetics and non-invasive body shaping. Today, the brand announced its latest FDA clearance for EMSCULPT, which is now FDA cleared to strengthen, firm and tone the arms and calves with the newly unveiled Small Contour Applicators. Building upon the existing clearances for the abdomen, buttocks, and thighs, the new Small Contour Applicator brings the unrivaled EMSCULPT results to even more key muscle groups, making it the ONLY non-invasive treatment that is FDA cleared to tone and strengthen the arms and calves as well.
Over the last several years, physicians have been applying energy for skin tightening and other aesthetic corrections; yet, most devices still lack real-time feedback features that intelligently react to how much of that energy is reaching intended tissue targets. One manufacturer has dramatically raised the technology bar, giving physicians automated, intelligent guidance leading to better outcomes.
Multispecialty stem-cell task force recommends facility accreditation and licensure of clinics performing any type of stem-cell treatment
NEW YORK, March 12, 2019 /PRNewswire/ – A recent article published in the Aesthetic Surgery Journal, the clinical, peer-reviewed journal of the American Society for Aesthetic Plastic Surgery (ASAPS/The Aesthetic Society) is calling for the FDA to expedite its oversight of companies and clinics offering stem-cell products and therapies.
Evolus (DWP-450; prabotulinumtoxinA) and Bonti (EB-001A; BoNT/E) report positive progress towards commercialization.
The Food and Drug Administration is in the process of evaluating scientific data on the safety of probiotics and postbiotics in cosmetics, said Linda Katz, M.D., director of the Office of Cosmetics and Color for the FDA.
The FDA is seeking permanent injunctions against a stem cell clinic in Florida and one in California to stop marketing stem cell products that lack FDA approval.